Equities

Guangxi Wuzhou Zhongheng Group Co Ltd

600252:SHH

Guangxi Wuzhou Zhongheng Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)1.92
  • Today's Change-0.02 / -1.03%
  • Shares traded23.07m
  • 1 Year change-27.55%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4,0354,1464,455
Total Receivables, Net1,8251,7631,775
Total Inventory776690658
Prepaid expenses7814366
Other current assets, total55544.39
Total current assets6,7696,7966,959
Property, plant & equipment, net1,5991,8351,836
Goodwill, net255320431
Intangibles, net461580529
Long term investments2,3051,9921,958
Note receivable - long term------
Other long term assets6032--
Total assets11,66611,75511,890
LIABILITIES
Accounts payable525428525
Accrued expenses140132121
Notes payable/short-term debt1,0331,1521,278
Current portion long-term debt/capital leases20416674
Other current liabilities, total627699711
Total current liabilities2,5292,5772,709
Total long term debt553650229
Total debt1,7901,9681,581
Deferred income tax624974
Minority interest1,7071,7722,067
Other liabilities, total245189188
Total liabilities5,0975,2375,266
SHAREHOLDERS EQUITY
Common stock3,4513,4753,475
Additional paid-in capital6.592575
Retained earnings (accumulated deficit)3,1553,1033,117
Treasury stock - common(49)(96)(150)
Unrealized gain (loss)--11107
Other equity, total5.52----
Total equity6,5696,5186,623
Total liabilities & shareholders' equity11,66611,75511,890
Total common shares outstanding3,4513,4753,475
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.